Friday, July 31, 2015

Sir Andrew Witty

GlaxoSmithKline CEO Andrew Witty was honored with a knighthood.

Sir Andrew Witty


Being a chief executive officer of a global pharmaceutical company is fine and all, but it's nothing like being a knight........we suppose.

Lest we get too far from the start of the year, we need to mention that GlaxoSmithKline CEO Andrew Witty is now Sir Andrew Witty, having been given a knighthood in the semi-annual British tradition of bestowing "New Year's Honours," on those showing "outstanding achievement and service across the whole of the United Kingdom."

The queen completes the other half of the semi-annual piece by announcing a list on her birthday, which is in June.

There had been some snickering in the pharmaceutical community - perhaps by cynical former colonists - that Witty had geared a few actions, or at least public discussion of them, in hopes of gaining such a title.

Witty spoke in 2011 of adding jobs in the UK. He also pushed for malaria vaccine to be distributed for lower costs in much of the world that still suffers from the disease.

The British government is involved in the process, which means there is always debate about who gets named. Witty does serve on an economic committee for Prime Minister David Cameron.

The full list and bits on the process can be found on the government site, which is here.



We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at

David Sell
Also on
letter icon Newsletter